Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients

Abstract

Post-diagnostic use of cholera vaccine can improve the prognosis in patients with colorectal cancer suggesting cholera toxin might have an antineoplastic effect. Here the authors perform a nationwide population-based study and report an association between cholera vaccine administration and reduction in prostate cancer mortality.